About: covid:9129d78b0d47b31ff06bb44bf06444e601e6ac95

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:9129d78b0d47b31ff06bb44bf06444e601e6ac95 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Du, Lanying Jiang, Shibo Peng, Bi-Hung Lustigman, Sara Algaissi, Abdullah Tao, Xinrong Agrawal, Anurodh Chen, Wen-Hsiang Pollet, Jeroen Strych, Ulrich Tseng, Chien-Te Baker, James Bottazzi, Maria Hotez Abef, Peter
is schema:about of	named entity 'candidate' named entity 'superior' named entity 'recombinant protein' named entity 'Immunity' named entity 'NEGATIVE' named entity 'SUPERIOR' named entity 'MICE' named entity 'DOMAIN' named entity 'cellular' named entity 'mortality' named entity 'severe acute respiratory syndrome (SARS)' named entity 'isolate' named entity 'adjuvant' named entity 'SARS-CoV' named entity 'virus' named entity 'mice' named entity 'SARS' named entity 'virus' named entity 'neutralizing antibodies' named entity 'protein' named entity 'SARS-CoV' named entity 'Alhydrogel' named entity 'severe acute respiratory syndrome' named entity 'antibodies' named entity 'Receptor' named entity 'hydrophobic interaction' named entity 'receptor' named entity 'peer review' named entity 'Alhydrogel' named entity 'supernatant' named entity 'Alhydrogel' named entity 'alum' named entity 'adjuvant' named entity 'adjuvanted' named entity 'SARS-CoV' named entity 'hematoxylin and eosin' named entity 'protein' named entity 'vaccine' named entity 'Th1/Th2' named entity 'immunopathology' named entity 'Neutralizing antibody' named entity 'protein' named entity 'vaccine' named entity 'protein' named entity 'neutralizing antibody' named entity 'neutralizing antibodies' named entity 'vaccine' named entity 'Alhydrogel' named entity 'immunopathology' named entity 'viral RNA' named entity 'infection' named entity 'non-human primates' named entity 'immunohistochemistry' named entity 'alum' named entity '1:25' named entity 'RBD' named entity 'neutralizing antibody' named entity 'positive controls' named entity '1:25' named entity 'titration' named entity 'Th17' named entity 'immune response' named entity 'Charles River' named entity 'infection' named entity 'SARS-CoV' named entity 'eosinophilic' named entity 'protein' named entity 'adjuvant' named entity 'protein' named entity 'Alhydrogel' named entity 'virus' named entity 'adjuvant' named entity 'dissolved oxygen' named entity 'Alhydrogel' named entity 'immunizations' named entity 'aluminum hydroxide' named entity 'infection' named entity 'modified vaccinia virus Ankara' named entity 'RBD' named entity 'RBD' named entity 'immunopathology' named entity 'SARS-CoV' named entity 'yeast' named entity 'supernatant' named entity 'eosinophilic' named entity 'sera'

Attributes

Values

Creator

Du, Lanying
Jiang, Shibo
Peng, Bi-Hung
Lustigman, Sara
Algaissi, Abdullah
Tao, Xinrong
Agrawal, Anurodh
Chen, Wen-Hsiang
Pollet, Jeroen
Strych, Ulrich
Tseng, Chien-Te
Baker, James
Bottazzi, Maria
Hotez Abef, Peter

is schema:about of

named entity 'candidate'
named entity 'superior'
named entity 'recombinant protein'
named entity 'Immunity'
named entity 'NEGATIVE'
named entity 'SUPERIOR'
named entity 'MICE'
named entity 'DOMAIN'
named entity 'cellular'
named entity 'mortality'
named entity 'severe acute respiratory syndrome (SARS)'
named entity 'isolate'
named entity 'adjuvant'
named entity 'SARS-CoV'
named entity 'virus'
named entity 'mice'
named entity 'SARS'
named entity 'virus'
named entity 'neutralizing antibodies'
named entity 'protein'
named entity 'SARS-CoV'
named entity 'Alhydrogel'
named entity 'severe acute respiratory syndrome'
named entity 'antibodies'
named entity 'Receptor'
named entity 'hydrophobic interaction'
named entity 'receptor'
named entity 'peer review'
named entity 'Alhydrogel'
named entity 'supernatant'
named entity 'Alhydrogel'
named entity 'alum'
named entity 'adjuvant'
named entity 'adjuvanted'
named entity 'SARS-CoV'
named entity 'hematoxylin and eosin'
named entity 'protein'
named entity 'vaccine'
named entity 'Th1/Th2'
named entity 'immunopathology'
named entity 'Neutralizing antibody'
named entity 'protein'
named entity 'vaccine'
named entity 'protein'
named entity 'neutralizing antibody'
named entity 'neutralizing antibodies'
named entity 'vaccine'
named entity 'Alhydrogel'
named entity 'immunopathology'
named entity 'viral RNA'
named entity 'infection'
named entity 'non-human primates'
named entity 'immunohistochemistry'
named entity 'alum'
named entity '1:25'
named entity 'RBD'
named entity 'neutralizing antibody'
named entity 'positive controls'
named entity '1:25'
named entity 'titration'
named entity 'Th17'
named entity 'immune response'
named entity 'Charles River'
named entity 'infection'
named entity 'SARS-CoV'
named entity 'eosinophilic'
named entity 'protein'
named entity 'adjuvant'
named entity 'protein'
named entity 'Alhydrogel'
named entity 'virus'
named entity 'adjuvant'
named entity 'dissolved oxygen'
named entity 'Alhydrogel'
named entity 'immunizations'
named entity 'aluminum hydroxide'
named entity 'infection'
named entity 'modified vaccinia virus Ankara'
named entity 'RBD'
named entity 'RBD'
named entity 'immunopathology'
named entity 'SARS-CoV'
named entity 'yeast'
named entity 'supernatant'
named entity 'eosinophilic'
named entity 'sera'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software